Axelar AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Private
- Established
- 2003-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.axelar.se
Clinical Trials
5
Active:1
Completed:4
Trial Phases
2 Phases
Phase 1:3
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (75.0%)Phase 2
1 (25.0%)A Study to Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant Tumors
Phase 1
Completed
- Conditions
- Solid TumorsHematological Malignancies
- First Posted Date
- 2012-11-14
- Last Posted Date
- 2014-04-07
- Lead Sponsor
- Axelar AB
- Target Recruit Count
- 13
- Registration Number
- NCT01725555
- Locations
- 🇸🇪
KFUE, Uppsala, Sweden
Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung
Phase 2
Completed
- Conditions
- Non-small-cell Lung CancerSquamous Cell CarcinomaAdenocarcinoma of the Lung
- Interventions
- First Posted Date
- 2012-03-23
- Last Posted Date
- 2013-12-05
- Lead Sponsor
- Axelar AB
- Target Recruit Count
- 100
- Registration Number
- NCT01561456
- Locations
- 🇧🇾
State Medical Institution: Republic Scientific Oncology Center, Poselok, Minsk Region, Belarus
🇧🇾Gomel Regional Clinical Oncology Center, Gomel, Belarus
🇧🇾Minsk City Clinical Oncology Center, Minsk, Belarus
A Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC)
- First Posted Date
- 2011-11-08
- Last Posted Date
- 2012-11-12
- Lead Sponsor
- Axelar AB
- Target Recruit Count
- 12
- Registration Number
- NCT01466647
- Locations
- 🇸🇪
KFUE, Uppsala, Sweden
🇸🇪University Hospital, Uppsala, Sweden
A Dose Escalating Clinical Trial of the IGF-1 Receptor Inhibitor AXL1717 in Patients With Advanced Cancer
- First Posted Date
- 2010-02-04
- Last Posted Date
- 2011-09-15
- Lead Sponsor
- Axelar AB
- Target Recruit Count
- 49
- Registration Number
- NCT01062620
- Locations
- 🇸🇪
Uppsala University Hospital, Uppsala, Sweden
News
No news found